In this report, the EMEA Drug-Eluting Balloon market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.
Geographically, this report split EMEA into Europe, the Middle East and Africa, With sales (K Units), revenue (Million USD), market share and growth rate of Drug-Eluting Balloon for these regions, from 2012 to 2022 (forecast)
Europe: Germany, France, UK, Russia, Italy and Benelux;
Middle East: Saudi Arabia, Israel, UAE and Iran;
Africa: South Africa, Nigeria, Egypt and Algeria.
EMEA Drug-Eluting Balloon market competition by top manufacturers/players, with Drug-Eluting Balloon sales volume (K Units), price (USD/Unit), revenue (Million USD) and market share for each manufacturer/player; the top players including
Boston Scientific
Medtronic
Cook Medical
C.R. Bard
B. Braun
Eurocor GmbH
Blue Medical
Bayer
Aachen Resonance
Acrostak
On the basis of product, this report displays the sales volume (K Units), revenue (Million USD), product price (USD/Unit), market share and growth rate of each type, primarily split into
Type I
Type II
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume (K Units), market share and growth rate of Drug-Eluting Balloon for each application, including
Treatment of In-stent Restenosis (ISR)
Treatment of Small Vessel Disease (SVD)
Treatment of Bifurcation Stenoses
Treatment of Primary Coronary Artery Disease
If you have any special requirements, please let us know and we will offer you the report as you want.
Table of Contents
EMEA (Europe, Middle East and Africa) Drug-Eluting Balloon Market Report 2017
1 Drug-Eluting Balloon Overview
1.1 Product Overview and Scope of Drug-Eluting Balloon
1.2 Classification of Drug-Eluting Balloon
1.2.1 EMEA Drug-Eluting Balloon Market Size (Sales) Comparison by Type (2012-2022)
1.2.2 EMEA Drug-Eluting Balloon Market Size (Sales) Market Share by Type (Product Category) in 2016
1.2.1 Type I
1.2.2 Type II
1.3 EMEA Drug-Eluting Balloon Market by Application/End Users
1.3.1 EMEA Drug-Eluting Balloon Sales (Volume) and Market Share Comparison by Application (2012-2022
1.3.2 Treatment of In-stent Restenosis (ISR)
1.3.3 Treatment of Small Vessel Disease (SVD)
1.3.4 Treatment of Bifurcation Stenoses
1.3.5 Treatment of Primary Coronary Artery Disease
1.4 EMEA Drug-Eluting Balloon Market by Region
1.4.1 EMEA Drug-Eluting Balloon Market Size (Value) Comparison by Region (2012-2022)
1.4.2 Europe Status and Prospect (2012-2022)
1.4.3 Middle East Status and Prospect (2012-2022)
1.4.4 Africa Status and Prospect (2012-2022)
1.5 EMEA Market Size (Value and Volume) of Drug-Eluting Balloon (2012-2022)
1.5.1 EMEA Drug-Eluting Balloon Sales and Growth Rate (2012-2022)
1.5.2 EMEA Drug-Eluting Balloon Revenue and Growth Rate (2012-2022)
2 EMEA Drug-Eluting Balloon Competition by Manufacturers/Players/Suppliers, Region, Type and Application
2.1 EMEA Drug-Eluting Balloon Market Competition by Players/Manufacturers
2.1.1 EMEA Drug-Eluting Balloon Sales Volume and Market Share of Major Players (2012-2017)
2.1.2 EMEA Drug-Eluting Balloon Revenue and Share by Players (2012-2017)
2.1.3 EMEA Drug-Eluting Balloon Sale Price by Players (2012-2017)
2.2 EMEA Drug-Eluting Balloon (Volume and Value) by Type/Product Category
2.2.1 EMEA Drug-Eluting Balloon Sales and Market Share by Type (2012-2017)
2.2.2 EMEA Drug-Eluting Balloon Revenue and Market Share by Type (2012-2017)
2.2.3 EMEA Drug-Eluting Balloon Sale Price by Type (2012-2017)
2.3 EMEA Drug-Eluting Balloon (Volume) by Application
2.4 EMEA Drug-Eluting Balloon (Volume and Value) by Region
2.4.1 EMEA Drug-Eluting Balloon Sales and Market Share by Region (2012-2017)
2.4.2 EMEA Drug-Eluting Balloon Revenue and Market Share by Region (2012-2017)
2.4.3 EMEA Drug-Eluting Balloon Sales Price by Region (2012-2017)
3 Europe Drug-Eluting Balloon (Volume, Value and Sales Price), by Players, Countries, Type and Application
3.1 Europe Drug-Eluting Balloon Sales and Value (2012-2017)
3.1.1 Europe Drug-Eluting Balloon Sales Volume and Growth Rate (2012-2017)
3.1.2 Europe Drug-Eluting Balloon Revenue and Growth Rate (2012-2017)
3.2 Europe Drug-Eluting Balloon Sales and Market Share by Type
3.3 Europe Drug-Eluting Balloon Sales and Market Share by Application
3.4 Europe Drug-Eluting Balloon Sales Volume and Value (Revenue) by Countries
3.4.1 Europe Drug-Eluting Balloon Sales Volume by Countries (2012-2017)
3.4.2 Europe Drug-Eluting Balloon Revenue by Countries (2012-2017)
3.4.3 Germany Drug-Eluting Balloon Sales and Growth Rate (2012-2017)
3.4.4 France Drug-Eluting Balloon Sales and Growth Rate (2012-2017)
3.4.5 UK Drug-Eluting Balloon Sales and Growth Rate (2012-2017)
3.4.6 Russia Drug-Eluting Balloon Sales and Growth Rate (2012-2017)
3.4.7 Italy Drug-Eluting Balloon Sales and Growth Rate (2012-2017)
3.4.8 Benelux Drug-Eluting Balloon Sales and Growth Rate (2012-2017)
4 Middle East Drug-Eluting Balloon (Volume, Value and Sales Price), by Region, Type and Application
4.1 Middle East Drug-Eluting Balloon Sales and Value (2012-2017)
4.1.1 Middle East Drug-Eluting Balloon Sales Volume and Growth Rate (2012-2017)
4.1.2 Middle East Drug-Eluting Balloon Revenue and Growth Rate (2012-2017)
4.2 Middle East Drug-Eluting Balloon Sales and Market Share by Type
4.3 Middle East Drug-Eluting Balloon Sales and Market Share by Application
4.4 Middle East Drug-Eluting Balloon Sales Volume and Value (Revenue) by Countries
4.4.1 Middle East Drug-Eluting Balloon Sales Volume by Countries (2012-2017)
4.4.2 Middle East Drug-Eluting Balloon Revenue by Countries (2012-2017)
4.4.3 Saudi Arabia Drug-Eluting Balloon Sales and Growth Rate (2012-2017)
4.4.4 Israel Drug-Eluting Balloon Sales and Growth Rate (2012-2017)
4.4.5 UAE Drug-Eluting Balloon Sales and Growth Rate (2012-2017)
4.4.6 Iran Drug-Eluting Balloon Sales and Growth Rate (2012-2017)
5 Africa Drug-Eluting Balloon (Volume, Value and Sales Price) by Players, Countries, Type and Application
5.1 Africa Drug-Eluting Balloon Sales and Value (2012-2017)
5.1.1 Africa Drug-Eluting Balloon Sales Volume and Growth Rate (2012-2017)
5.1.2 Africa Drug-Eluting Balloon Revenue and Growth Rate (2012-2017)
5.2 Africa Drug-Eluting Balloon Sales and Market Share by Type
5.3 Africa Drug-Eluting Balloon Sales and Market Share by Application
5.4 Africa Drug-Eluting Balloon Sales Volume and Value (Revenue) by Countries
5.4.1 Africa Drug-Eluting Balloon Sales Volume by Countries (2012-2017)
5.4.2 Africa Drug-Eluting Balloon Revenue by Countries (2012-2017)
5.4.3 South Africa Drug-Eluting Balloon Sales and Growth Rate (2012-2017)
5.4.4 Nigeria Drug-Eluting Balloon Sales and Growth Rate (2012-2017)
5.4.5 Egypt Drug-Eluting Balloon Sales and Growth Rate (2012-2017)
5.4.6 Algeria Drug-Eluting Balloon Sales and Growth Rate (2012-2017)
6 EMEA Drug-Eluting Balloon Manufacturers/Players Profiles and Sales Data
6.1 Boston Scientific
6.1.1 Company Basic Information, Manufacturing Base and Competitors
6.1.2 Drug-Eluting Balloon Product Type, Application and Specification
6.1.2.1 Product A
6.1.2.2 Product B
6.1.3 Boston Scientific Drug-Eluting Balloon Sales, Revenue, Price and Gross Margin (2012-2017)
6.1.4 Main Business/Business Overview
6.2 Medtronic
6.2.1 Company Basic Information, Manufacturing Base and Competitors
6.2.2 Drug-Eluting Balloon Product Type, Application and Specification
6.2.2.1 Product A
6.2.2.2 Product B
6.2.3 Medtronic Drug-Eluting Balloon Sales, Revenue, Price and Gross Margin (2012-2017)
6.2.4 Main Business/Business Overview
6.3 Cook Medical
6.3.1 Company Basic Information, Manufacturing Base and Competitors
6.3.2 Drug-Eluting Balloon Product Type, Application and Specification
6.3.2.1 Product A
6.3.2.2 Product B
6.3.3 Cook Medical Drug-Eluting Balloon Sales, Revenue, Price and Gross Margin (2012-2017)
6.3.4 Main Business/Business Overview
6.4 C.R. Bard
6.4.1 Company Basic Information, Manufacturing Base and Competitors
6.4.2 Drug-Eluting Balloon Product Type, Application and Specification
6.4.2.1 Product A
6.4.2.2 Product B
6.4.3 C.R. Bard Drug-Eluting Balloon Sales, Revenue, Price and Gross Margin (2012-2017)
6.4.4 Main Business/Business Overview
6.5 B. Braun
6.5.1 Company Basic Information, Manufacturing Base and Competitors
6.5.2 Drug-Eluting Balloon Product Type, Application and Specification
6.5.2.1 Product A
6.5.2.2 Product B
6.5.3 B. Braun Drug-Eluting Balloon Sales, Revenue, Price and Gross Margin (2012-2017)
6.5.4 Main Business/Business Overview
6.6 Eurocor GmbH
6.6.1 Company Basic Information, Manufacturing Base and Competitors
6.6.2 Drug-Eluting Balloon Product Type, Application and Specification
6.6.2.1 Product A
6.6.2.2 Product B
6.6.3 Eurocor GmbH Drug-Eluting Balloon Sales, Revenue, Price and Gross Margin (2012-2017)
6.6.4 Main Business/Business Overview
6.7 Blue Medical
6.7.1 Company Basic Information, Manufacturing Base and Competitors
6.7.2 Drug-Eluting Balloon Product Type, Application and Specification
6.7.2.1 Product A
6.7.2.2 Product B
6.7.3 Blue Medical Drug-Eluting Balloon Sales, Revenue, Price and Gross Margin (2012-2017)
6.7.4 Main Business/Business Overview
6.8 Bayer
6.8.1 Company Basic Information, Manufacturing Base and Competitors
6.8.2 Drug-Eluting Balloon Product Type, Application and Specification
6.8.2.1 Product A
6.8.2.2 Product B
6.8.3 Bayer Drug-Eluting Balloon Sales, Revenue, Price and Gross Margin (2012-2017)
6.8.4 Main Business/Business Overview
6.9 Aachen Resonance
6.9.1 Company Basic Information, Manufacturing Base and Competitors
6.9.2 Drug-Eluting Balloon Product Type, Application and Specification
6.9.2.1 Product A
6.9.2.2 Product B
6.9.3 Aachen Resonance Drug-Eluting Balloon Sales, Revenue, Price and Gross Margin (2012-2017)
6.9.4 Main Business/Business Overview
6.10 Acrostak
6.10.1 Company Basic Information, Manufacturing Base and Competitors
6.10.2 Drug-Eluting Balloon Product Type, Application and Specification
6.10.2.1 Product A
6.10.2.2 Product B
6.10.3 Acrostak Drug-Eluting Balloon Sales, Revenue, Price and Gross Margin (2012-2017)
6.10.4 Main Business/Business Overview
7 Drug-Eluting Balloon Manufacturing Cost Analysis
7.1 Drug-Eluting Balloon Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Price Trend of Key Raw Materials
7.1.3 Key Suppliers of Raw Materials
7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.2.1 Raw Materials
7.2.2 Labor Cost
7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Drug-Eluting Balloon
8 Industrial Chain, Sourcing Strategy and Downstream Buyers
8.1 Drug-Eluting Balloon Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Drug-Eluting Balloon Major Manufacturers in 2016
8.4 Downstream Buyers
9 Marketing Strategy Analysis, Distributors/Traders
9.1 Marketing Channel
9.1.1 Direct Marketing
9.1.2 Indirect Marketing
9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
9.2.1 Pricing Strategy
9.2.2 Brand Strategy
9.2.3 Target Client
9.3 Distributors/Traders List
10 Market Effect Factors Analysis
10.1 Technology Progress/Risk
10.1.1 Substitutes Threat
10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change
11 EMEA Drug-Eluting Balloon Market Forecast (2017-2022)
11.1 EMEA Drug-Eluting Balloon Sales, Revenue and Price Forecast (2017-2022)
11.1.1 EMEA Drug-Eluting Balloon Sales and Growth Rate Forecast (2017-2022)
11.1.2 EMEA Drug-Eluting Balloon Revenue and Growth Rate Forecast (2017-2022)
11.1.3 EMEA Drug-Eluting Balloon Price and Trend Forecast (2017-2022)
11.2 EMEA Drug-Eluting Balloon Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.3 Europe Drug-Eluting Balloon Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.4 Middle Eastt Drug-Eluting Balloon Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.5 Africa Drug-Eluting Balloon Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.6 EMEA Drug-Eluting Balloon Sales Forecast by Type (2017-2022)
11.7 EMEA Drug-Eluting Balloon Sales Forecast by Application (2017-2022)
12 Research Findings and Conclusion
13 Appendix
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
List of Tables and Figures
Figure Product Picture of Drug-Eluting Balloon
Figure EMEA Drug-Eluting Balloon Sales Volume (K Units) by Type (2012-2022)
Figure EMEA Drug-Eluting Balloon Sales Volume Market Share by Type (Product Category) in 2016
Figure Type I Product Picture
Figure Type II Product Picture
Figure EMEA Drug-Eluting Balloon Sales Volume (K Units) by Application (2012-2022)
Figure EMEA Sales Market Share of Drug-Eluting Balloon by Application in 2016
Figure Treatment of In-stent Restenosis (ISR) Examples
Table Key Downstream Customer in Treatment of In-stent Restenosis (ISR)
Figure Treatment of Small Vessel Disease (SVD) Examples
Table Key Downstream Customer in Treatment of Small Vessel Disease (SVD)
Figure Treatment of Bifurcation Stenoses Examples
Table Key Downstream Customer in Treatment of Bifurcation Stenoses
Figure Treatment of Primary Coronary Artery Disease Examples
Table Key Downstream Customer in Treatment of Primary Coronary Artery Disease
Figure EMEA Drug-Eluting Balloon Market Size (Million USD) by Region (2012-2022)
Figure Europe Drug-Eluting Balloon Revenue (Million USD) and Growth Rate (2012-2022)
Figure Europe Drug-Eluting Balloon Revenue (Million USD) Status and Forecast by Countries
Figure Middle East Drug-Eluting Balloon Revenue (Million USD) and Growth Rate (2012-2022)
Figure Middle East Drug-Eluting Balloon Revenue (Million USD) Status and Forecast by Countries
Figure Africa Drug-Eluting Balloon Revenue (Million USD) and Growth Rate (2012-2022)
Figure Africa Drug-Eluting Balloon Revenue (Million USD) Status and Forecast by Countries
Figure EMEA Drug-Eluting Balloon Sales Volume and Growth Rate (2012-2022)
Figure EMEA Drug-Eluting Balloon Revenue (Million USD) and Growth Rate (2012-2022)
Figure EMEA Drug-Eluting Balloon Market Major Players Product Sales Volume (K Units) (2012-2017)
Table EMEA Drug-Eluting Balloon Sales Volume (K Units) of Major Players (2012-2017)
Table EMEA Drug-Eluting Balloon Sales Share by Players (2012-2017)
Figure 2016 Drug-Eluting Balloon Sales Share by Players
Figure 2017 Drug-Eluting Balloon Sales Share by Players
Figure EMEA Drug-Eluting Balloon Market Major Players Product Revenue (Million USD) (2012-2017)
Table EMEA Drug-Eluting Balloon Revenue (Million USD) by Players (2012-2017)
Table EMEA Drug-Eluting Balloon Revenue Share by Players (2012-2017)
Table 2016 EMEA Drug-Eluting Balloon Revenue Share by Players
Table 2017 EMEA Drug-Eluting Balloon Revenue Share by Players
Table EMEA Drug-Eluting Balloon Sale Price (USD/Unit) by Players (2012-2017)
Table EMEA Drug-Eluting Balloon Sales (K Units) and Market Share by Type (2012-2017)
Table EMEA Drug-Eluting Balloon Sales Share by Type (2012-2017)
Figure Sales Market Share of Drug-Eluting Balloon by Type (2012-2017)
Figure EMEA Drug-Eluting Balloon Sales Market Share by Type (2012-2017)
Table EMEA Drug-Eluting Balloon Revenue (Million USD) and Market Share by Type (2012-2017)
Table EMEA Drug-Eluting Balloon Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Drug-Eluting Balloon by Type in 2016
Table EMEA Drug-Eluting Balloon Sale Price (USD/Unit) by Type (2012-2017)
Table EMEA Drug-Eluting Balloon Sales (K Units) and Market Share by Application (2012-2017)
Table EMEA Drug-Eluting Balloon Sales Share by Application (2012-2017)
Figure Sales Market Share of Drug-Eluting Balloon by Application (2012-2017)
Figure EMEA Drug-Eluting Balloon Sales Market Share by Application in 2016
Table EMEA Drug-Eluting Balloon Sales (K Units) and Market Share by Region (2012-2017)
Table EMEA Drug-Eluting Balloon Sales Share by Region (2012-2017)
Figure Sales Market Share of Drug-Eluting Balloon by Region (2012-2017)
Figure EMEA Drug-Eluting Balloon Sales Market Share in 2016
Table EMEA Drug-Eluting Balloon Revenue (Million USD) and Market Share by Region (2012-2017)
Table EMEA Drug-Eluting Balloon Revenue Share by Region (2012-2017)
Figure Revenue Market Share of Drug-Eluting Balloon by Region (2012-2017)
Figure EMEA Drug-Eluting Balloon Revenue Market Share Regions in 2016
Table EMEA Drug-Eluting Balloon Sales Price (USD/Unit) by Region (2012-2017)
Figure Europe Drug-Eluting Balloon Sales (K Units) and Growth Rate (2012-2017)
Figure Europe Drug-Eluting Balloon Revenue and Growth Rate (2012-2017)
Table Europe Drug-Eluting Balloon Sales (K Units) by Type (2012-2017)
Table Europe Drug-Eluting Balloon Market Share by Type (2012-2017)
Figure Europe Drug-Eluting Balloon Market Share by Type in 2016
Table Europe Drug-Eluting Balloon Sales (K Units) by Application (2012-2017)
Table Europe Drug-Eluting Balloon Market Share by Application (2012-2017)
Figure Europe Drug-Eluting Balloon Market Share by Application in 2016
Table Europe Drug-Eluting Balloon Sales (K Units) by Countries (2012-2017)
Table Europe Drug-Eluting Balloon Sales Market Share by Countries (2012-2017)
Figure Europe Drug-Eluting Balloon Sales Market Share by Countries (2012-2017)
Figure Europe Drug-Eluting Balloon Sales Market Share by Countries in 2016
Table Europe Drug-Eluting Balloon Revenue (Million USD) by Countries (2012-2017)
Table Europe Drug-Eluting Balloon Revenue Market Share by Countries (2012-2017)
Figure Europe Drug-Eluting Balloon Revenue Market Share by Countries (2012-2017)
Figure Europe Drug-Eluting Balloon Revenue Market Share by Countries in 2016
Figure Germany Drug-Eluting Balloon Sales (K Units) and Growth Rate (2012-2017)
Figure France Drug-Eluting Balloon Sales (K Units) and Growth Rate (2012-2017)
Figure UK Drug-Eluting Balloon Sales (K Units) and Growth Rate (2012-2017)
Figure Russia Drug-Eluting Balloon Sales (K Units) and Growth Rate (2012-2017)
Figure Italy Drug-Eluting Balloon Sales (K Units) and Growth Rate (2012-2017)
Figure Benelux Drug-Eluting Balloon Sales (K Units) and Growth Rate (2012-2017)
Figure Middle East Drug-Eluting Balloon Sales (K Units) and Growth Rate (2012-2017)
Figure Middle East Drug-Eluting Balloon Revenue (Million USD) and Growth Rate (2012-2017)
Table Middle East Drug-Eluting Balloon Sales (K Units) by Type (2012-2017)
Table Middle East Drug-Eluting Balloon Market Share by Type (2012-2017)
Figure Middle East Drug-Eluting Balloon Market Share by Type (2012-2017)
Table Middle East Drug-Eluting Balloon Sales (K Units) by Applications (2012-2017)
Table Middle East Drug-Eluting Balloon Market Share by Applications (2012-2017)
Figure Middle East Drug-Eluting Balloon Sales Market Share by Application in 2016
Table Middle East Drug-Eluting Balloon Sales Volume (K Units) by Countries (2012-2017)
Table Middle East Drug-Eluting Balloon Sales Volume Market Share by Countries (2012-2017)
Figure Middle East Drug-Eluting Balloon Sales Volume Market Share by Countries in 2016
Table Middle East Drug-Eluting Balloon Revenue (Million USD) by Countries (2012-2017)
Table Middle East Drug-Eluting Balloon Revenue Market Share by Countries (2012-2017)
Figure Middle East Drug-Eluting Balloon Revenue Market Share by Countries (2012-2017)
Figure Middle East Drug-Eluting Balloon Revenue Market Share by Countries in 2016
Figure Saudi Arabia Drug-Eluting Balloon Sales (K Units) and Growth Rate (2012-2017)
Figure Israel Drug-Eluting Balloon Sales (K Units) and Growth Rate (2012-2017)
Figure UAE Drug-Eluting Balloon Sales (K Units) and Growth Rate (2012-2017)
Figure Iran Drug-Eluting Balloon Sales (K Units) and Growth Rate (2012-2017)
Figure Africa Drug-Eluting Balloon Sales (K Units) and Growth Rate (2012-2017)
Figure Africa Drug-Eluting Balloon Revenue (Million USD) and Growth Rate (2012-2017)
Table Africa Drug-Eluting Balloon Sales (K Units) by Type (2012-2017)
Table Africa Drug-Eluting Balloon Sales Market Share by Type (2012-2017)
Figure Africa Drug-Eluting Balloon Sales Market Share by Type (2012-2017)
Figure Africa Drug-Eluting Balloon Sales Market Share by Type in 2016
Table Africa Drug-Eluting Balloon Sales (K Units) by Application (2012-2017)
Table Africa Drug-Eluting Balloon Sales Market Share by Application (2012-2017)
Figure Africa Drug-Eluting Balloon Sales Market Share by Application (2012-2017)
Table Africa Drug-Eluting Balloon Sales Volume (K Units) by Countries (2012-2017)
Table Africa Drug-Eluting Balloon Sales Market Share by Countries (2012-2017)
Figure Africa Drug-Eluting Balloon Sales Market Share by Countries (2012-2017)
Figure Africa Drug-Eluting Balloon Sales Market Share by Countries in 2016
Table Africa Drug-Eluting Balloon Revenue (Million USD) by Countries (2012-2017)
Table Africa Drug-Eluting Balloon Revenue Market Share by Countries (2012-2017)
Figure Africa Drug-Eluting Balloon Revenue Market Share by Countries (2012-2017)
Figure Africa Drug-Eluting Balloon Revenue Market Share by Countries in 2016
Figure South Africa Drug-Eluting Balloon Sales (K Units) and Growth Rate (2012-2017)
Figure Nigeria Drug-Eluting Balloon Sales (K Units) and Growth Rate (2012-2017)
Figure Egypt Drug-Eluting Balloon Sales (K Units) and Growth Rate (2012-2017)
Figure Algeria Drug-Eluting Balloon Sales (K Units) and Growth Rate (2012-2017)
Table Boston Scientific Drug-Eluting Balloon Basic Information List
Table Boston Scientific Drug-Eluting Balloon Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Boston Scientific Drug-Eluting Balloon Sales (K Units) and Growth Rate (2012-2017)
Figure Boston Scientific Drug-Eluting Balloon Sales Market Share in EMEA (2012-2017)
Figure Boston Scientific Drug-Eluting Balloon Revenue Market Share in EMEA (2012-2017)
Table Medtronic Drug-Eluting Balloon Basic Information List
Table Medtronic Drug-Eluting Balloon Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Medtronic Drug-Eluting Balloon Sales (K Units) and Growth Rate (2012-2017)
Figure Medtronic Drug-Eluting Balloon Sales Market Share in EMEA (2012-2017)
Figure Medtronic Drug-Eluting Balloon Revenue Market Share in EMEA (2012-2017)
Table Cook Medical Drug-Eluting Balloon Basic Information List
Table Cook Medical Drug-Eluting Balloon Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Cook Medical Drug-Eluting Balloon Sales (K Units) and Growth Rate (2012-2017)
Figure Cook Medical Drug-Eluting Balloon Sales Market Share in EMEA (2012-2017)
Figure Cook Medical Drug-Eluting Balloon Revenue Market Share in EMEA (2012-2017)
Table C.R. Bard Drug-Eluting Balloon Basic Information List
Table C.R. Bard Drug-Eluting Balloon Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure C.R. Bard Drug-Eluting Balloon Sales (K Units) and Growth Rate (2012-2017)
Figure C.R. Bard Drug-Eluting Balloon Sales Market Share in EMEA (2012-2017)
Figure C.R. Bard Drug-Eluting Balloon Revenue Market Share in EMEA (2012-2017)
Table B. Braun Drug-Eluting Balloon Basic Information List
Table B. Braun Drug-Eluting Balloon Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure B. Braun Drug-Eluting Balloon Sales (K Units) and Growth Rate (2012-2017)
Figure B. Braun Drug-Eluting Balloon Sales Market Share in EMEA (2012-2017)
Figure B. Braun Drug-Eluting Balloon Revenue Market Share in EMEA (2012-2017)
Table Eurocor GmbH Drug-Eluting Balloon Basic Information List
Table Eurocor GmbH Drug-Eluting Balloon Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Eurocor GmbH Drug-Eluting Balloon Sales (K Units) and Growth Rate (2012-2017)
Figure Eurocor GmbH Drug-Eluting Balloon Sales Market Share in EMEA (2012-2017)
Figure Eurocor GmbH Drug-Eluting Balloon Revenue Market Share in EMEA (2012-2017)
Table Blue Medical Drug-Eluting Balloon Basic Information List
Table Blue Medical Drug-Eluting Balloon Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Blue Medical Drug-Eluting Balloon Sales (K Units) and Growth Rate (2012-2017)
Figure Blue Medical Drug-Eluting Balloon Sales Market Share in EMEA (2012-2017)
Figure Blue Medical Drug-Eluting Balloon Revenue Market Share in EMEA (2012-2017)
Table Bayer Drug-Eluting Balloon Basic Information List
Table Bayer Drug-Eluting Balloon Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Bayer Drug-Eluting Balloon Sales (K Units) and Growth Rate (2012-2017)
Figure Bayer Drug-Eluting Balloon Sales Market Share in EMEA (2012-2017)
Figure Bayer Drug-Eluting Balloon Revenue Market Share in EMEA (2012-2017)
Table Aachen Resonance Drug-Eluting Balloon Basic Information List
Table Aachen Resonance Drug-Eluting Balloon Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Aachen Resonance Drug-Eluting Balloon Sales (K Units) and Growth Rate (2012-2017)
Figure Aachen Resonance Drug-Eluting Balloon Sales Market Share in EMEA (2012-2017)
Figure Aachen Resonance Drug-Eluting Balloon Revenue Market Share in EMEA (2012-2017)
Table Acrostak Drug-Eluting Balloon Basic Information List
Table Acrostak Drug-Eluting Balloon Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Acrostak Drug-Eluting Balloon Sales (K Units) and Growth Rate (2012-2017)
Figure Acrostak Drug-Eluting Balloon Sales Market Share in EMEA (2012-2017)
Figure Acrostak Drug-Eluting Balloon Revenue Market Share in EMEA (2012-2017)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Drug-Eluting Balloon
Figure Manufacturing Process Analysis of Drug-Eluting Balloon
Figure Drug-Eluting Balloon Industrial Chain Analysis
Table Raw Materials Sources of Drug-Eluting Balloon Major Manufacturers in 2016
Table Major Buyers of Drug-Eluting Balloon
Table Distributors/Traders List
Figure EMEA Drug-Eluting Balloon Sales (K Units) and Growth Rate Forecast (2017-2022)
Figure EMEA Drug-Eluting Balloon Revenue and Growth Rate Forecast (2017-2022)
Figure EMEA Drug-Eluting Balloon Price (USD/Unit) and Trend Forecast (2017-2022)
Table EMEA Drug-Eluting Balloon Sales (K Units) Forecast by Region (2017-2022)
Figure EMEA Drug-Eluting Balloon Sales Market Share Forecast by Region (2017-2022)
Table EMEA Drug-Eluting Balloon Revenue (Million USD) Forecast by Region (2017-2022)
Figure EMEA Drug-Eluting Balloon Revenue Market Share Forecast by Region (2017-2022)
Table Europe Drug-Eluting Balloon Sales (K Units) Forecast by Countries (2017-2022)
Figure Europe Drug-Eluting Balloon Sales Market Share Forecast by Countries (2017-2022)
Table Europe Drug-Eluting Balloon Revenue (Million USD) Forecast by Countries (2017-2022)
Figure Europe Drug-Eluting Balloon Revenue Market Share Forecast by Countries (2017-2022)
Table Middle East Drug-Eluting Balloon Sales (K Units) Forecast by Countries (2017-2022)
Figure Middle East Drug-Eluting Balloon Sales Market Share Forecast by Countries (2017-2022)
Table Middle East Drug-Eluting Balloon Revenue (Million USD) Forecast by Countries (2017-2022)
Figure Middle East Drug-Eluting Balloon Revenue Market Share Forecast by Countries (2017-2022)
Table Africa Drug-Eluting Balloon Sales (K Units) Forecast by Countries (2017-2022)
Figure Africa Drug-Eluting Balloon Sales Market Share Forecast by Countries (2017-2022)
Table Africa Drug-Eluting Balloon Revenue (Million USD) Forecast by Countries (2017-2022)
Figure Africa Drug-Eluting Balloon Revenue Market Share Forecast by Countries (2017-2022)
Table EMEA Drug-Eluting Balloon Sales (K Units) Forecast by Type (2017-2022)
Figure EMEA Drug-Eluting Balloon Sales Market Share Forecast by Type (2017-2022)
Table EMEA Drug-Eluting Balloon Sales (K Units) Forecast by Application (2017-2022)
Figure EMEA Drug-Eluting Balloon Sales Market Share Forecast by Application (2017-2022)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
